Dis-Chem says the chronic medicine clients who ditched it after its CEO called for a moratorium on the hiring of whites, appear to be returning to the JSE-listed pharmaceutical retailer's dispensaries.
Speaking after the release of results for the 12 months to end-February 2023, CFO Rui Morais told News24 that there were positive signs of a recovery in the chronic medicine segment.
Last year, CEO Ivan Saltzman called for a moratorium on white hires in a memorandum to staff as part of efforts to meet employment equity targets.